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Expressed in Mouse Tissues With
Metabolic Function
Tatiana Danilova, Emilia Galli, Emmi Pakarinen, Erik Palm, Päivi Lindholm, Mart Saarma
and Maria Lindahl*
HILIFE, Institute of Biotechnology, University of Helsinki, Helsinki, Finland
Mesencephalic astrocyte-derived neurotrophic factor (MANF) and cerebral dopamine
neurotrophic factor (CDNF) form a family of atypical growth factors discovered for their
neuroprotective properties in the central nervous system (CNS) in animal models of
neurodegenerative diseases. Although their mechanism of protective action still remains
unclear, it has been suggested that both MANF and CDNF promote cell survival
through regulating the unfolded protein response (UPR), thereby relieving endoplasmic
reticulum (ER) stress. Recent studies identified MANF for its emerging roles in metabolic
function, inflammation and pancreatic β-cells. We have found that MANF deletion
from the pancreas and β-cells leads to postnatal depletion of β-cells and diabetes.
Moreover, global MANF-deficiency in mice results in severe diabetes-independent growth
retardation. As the expression pattern of MANF inmouse tissues has not been extensively
studied, we set out to thoroughly investigate MANF expression in embryonic and
adult mice using immunohistochemistry, histochemical X-gal staining, enzyme-linked
immunosorbent assay (ELISA), and quantitative reverse transcription PCR (RT-qPCR).
We found that MANF is highly expressed in brain neurons regulating energy homeostasis
and appetite, as well as in hypothalamic nuclei producing hormones and neuropeptides
important for different body functions. Strong expression of MANF was also observed
in peripheral mouse tissues and cells with high secretory and metabolic function. These
include pituitary gland and interestingly we found that the anterior pituitary gland is smaller
in MANF-deficient mice compared to wild-type mice. Consequently, we found reduction
in the number of growth hormone- and prolactin-producing cells. This combined with
increased expression of UPR genes, reduced number of proliferating cells in the anterior
pituitary and dysregulated expression of pituitary hormones might contribute to the
severe growth defect seen in the MANF knockout mice. Moreover, in this study we
compared MANF and CDNF levels in mouse tissues. Unlike MANF, CDNF protein levels
are generally lower in mouse tissues, and the highest levels of CDNF was observed in
the tissues with high-energy demands and oxidative roles, including heart, muscle, testis,
and brown adipose tissue.
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INTRODUCTION
MANF and CDNF are small, two-domain unconventional
neurotrophic factors localized to the ER but MANF is also found
secreted upon ER stress-induction from cells (1–5).
Both MANF and CDNF are protective and restorative in
rodent models of neurodegenerative diseases (6–13). MANF
promotes tissue repair and regeneration in the injured retina
by modulation of anti-inflammatory response (14). Notably, the
trophic effects of MANF apply not only to neurons but also to
other cell types. MANFwas found to rescue cardiomyocytes from
death in a rodent model of heart ischemia (15). MANF delivered
by virus vector to the mouse pancreas induced regeneration of β-
cells in vivo in a Type 1 diabetes (T1D) model and importantly,
recombinant human (rh)MANF increased proliferation of both
mouse and human β-cells in vitro (4, 5, 16). Moreover, rhMANF
also protected mouse β-cells from thapsigargin-induced cell
death and partially also human β-cells from cytokine-induced cell
death (4, 17).
The protective and restorative effects of MANF and CDNF
in rodent disease models and in cultured cells in vitro have
been suggested to depend on their role in modulating UPR in
ER stress (18, 19). The ultimate proof for the role of MANF
in regulating/dampening ER stress came from our studies in
MANF knockout mice showing that insulin-producing β-cells
lacking MANF develop severe chronic ER stress leading to
decreased β-cell proliferation and cell death (5, 16). ER stress
in cells is caused by the accumulation and aggregation of
unfolded or misfolded proteins in the ER, which activates the
UPR, a signaling cascades attempting to restore the organelle’s
physiological activity (20). The UPR signaling in mammalian
cells is mediated via three major ER transmembrane sensors,
protein kinase RNA(PKR)-like ER endoplasmic reticulum kinase
(PERK), endoribonuclease inositol-requiring protein 1 (IRE1
α and β) and activating transcription factor 6 (ATF6 α
and β) (21). The activation of these sensors leads to the
initiation of downstream signaling cascades aiming to restore
the normal function of the cell. However, if prolonged and
unresolved, UPR leads to cell death (22–24). Inactivation of
several UPR genes in mice and humans cause metabolic
phenotypes, skeletal, and brain defects (25–30). In addition,
dysregulation of the UPR has been suggested to contribute
to the pathogenesis of several human disorders, including
neurodegenerative diseases, diabetes, metabolic disorders, and
autoimmune diseases (31, 32).
Increasing evidence is emerging for the importance of the
proper expression level of MANF protein in cells and tissues
involved in energy metabolism (33, 34). In addition, data on the
circulating levels of MANF in newly diagnosed diabetes patients
support roles for MANF in the regulation of systemic metabolic
homeostasis (35, 36). MANF-deficiency in mice results in β-cell
death and diabetes, and a severe diabetes-independent growth
defect (16). In addition, in a clinical exome sequencing screen
a homozygote missense mutation in the MANF gene indicative
of deficient MANF expression was found in a patient suffering
from Type 2 diabetes and obesity, short stature, microcephaly,
and other anomalies (37). Reduced MANF expression in β-cells
seems to underlie enhanced susceptibility for β-cell apoptosis and
diabetes in mice and humans (38).
Our studies and others have demonstrated wide MANF
and CDNF expression in both rodent and human brain (5, 6,
13, 33, 39, 40). In peripheral tissues, we have found strong
expression of MANF in tissues with a high secretory function
such as pancreatic exocrine acinar cells and endocrine islet β-
cells, salivary glands, and testicular spermatocytes (5, 16, 39).
In addition, the level of MANF protein expression seems to
reduce with aging in rodent brain and other metabolic tissues
and flies (34, 40). In peripheral mouse tissues, CDNF expression
was observed in the adult mouse heart, muscle, salivary glands,
testicles, and lungs (6). Hence, it seems that expression patterns
of MANF and CDNF partly overlap in the mouse neuronal and
non-neuronal tissues.
However, a comprehensive comparison of the expression
levels of MANF and CDNF has not been made. In addition,
a detailed characterization of MANF expression in metabolic
and secretory tissues in mice is lacking. In this study, we have
carefully analyzed the expression pattern of MANF in the mouse
embryo and juvenile mouse tissues by immunohistochemistry
using MANF antibodies validated against Manf−/− mouse
tissues. In addition, MANF and CDNF mRNA and protein
levels in different mouse tissues were compared using and RT-
qPCR and in-lab ELISAs, which were constructed and validated
for quantitation of mouse MANF and CDNF proteins. We
observed that MANF expression is high in mouse tissues and
brain areas responsible for metabolic regulation of feeding and
energy balance, and in cells of peripheral tissues with high
secretory function. The expression of MANF was especially high
in several hypothalamic nuclei, the mouse pituitary, thyroid
and adrenal glands, all tissues involved in the neuro-endocrine
axes important for the regulation of feeding, stress, growth,
and development. Consequently, we found that the size of the
endocrine adenohypophysis compared to the whole pituitary
gland was decreased in theManf−/− mice. The reduced size was
consistent with the decreased number of cells producing growth
hormone and prolactin, dysregulated expression of pituitary
hormones, increased ER stress and apoptosis, all which might
contribute to the severe growth defect seen in theManf−/− mice.
METHODS
Mice and Targeted Embryonic Stem Cells
Mice used in this study were generated from heterozygote
breeding of Manf +/− and Cdnf +/− mice (16, 18) (Lindahl
et al., submitted manuscript). Tissues from Manf−/−
and Cdnf−/− animals were used as a negative control in
immunohistochemistry and ELISA. All mice were maintained
on ICR background and housed on a 12-h dark/light cycle, ad
libitum fed and with free access to water. Finnish Animal Ethics
Committee of the State Provincial Office of Southern Finland
approved all experimental procedures involving mice.
MANF (Manf_D06, C57BL/6N-Manftm1a(KOMP)Wtsi) (and
CDNF (Cdnf_CO1, C57BL/6N-Cdnftm1a(KOMP)Wtsi) targeted
embryonic stem cell clones were generated by the trans-National
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Institutes of Health (NIH) KnockoutMouse Project and obtained
from the KOMP Repository (http://www.komp.org).
Islet Isolation
Islet isolation was performed as described previously (16). In
brief, islets from 8 weeks old mice were isolated by standard
collagenase (Collagenase P; Roche Diagnostic) digestion followed
by handpicking under a stereomicroscope.
RNA Isolation, Reverse Transcription
Quantitative PCR (RT-qPCR)
Mouse tissues were collected and fast frozen in liquid nitrogen.
RNA isolation, reverse transcription, and RT-qPCR were
performed as described previously (16). Total RNA was isolated
from mouse tissues or isolated islets by homogenizing them in
TriReagent R© (Molecular Research Center) according to standard
protocol procedures. The RNA amount and purity was measured
by NanoDrop ND-1000 spectrophotometer (Thermo Scientific).
Glycogen (RNA grade, Thermo Scientific) was used during
the RNA precipitation procedure to visualize the pellet. cDNA
synthesis was done by reverse transcription reactions with
RevertAidTM Premium Reverse Transcriptase (Fermentas UAB,
Thermo Fisher Scientific Inc.) according to the manufacturer’s
protocol. RT-qPCR was performed using LightCycler R© 480
SYBR Green I Master (Roche Diagnostics GmbH) and Roche
LightCycler R© 480 Real-Time PCR System. The expression levels
were normalized to the levels of β-actin in the same samples.
Primer sequences forGh, Prl, Pit1, Tshβ, mPomc, Fsh, Lhb, Grp78,
Chop, sXbp1, tXbp1, Atf4, Atf6α, Atf6β , Manf genes used in this
study were from (5, 16, 41). Primer sequences for Cdnf gene were
F 5′-AGC TGC TCAACT TTT GCT CA-3′, R 5′-TAGGAT CTT
GGT GGC TGC AT-3′.
Protein Isolation
Mouse tissue samples were homogenized in ice-cold lysis
buffer (100mM Tris-HCl, pH 7.5, 300mM NaCl, 4mM
EDTA, 0.2% Triton X-100, 2mM phenylmethylsulfonyl fluoride
(PMSF), 1mM sodium orthovanadate, protease inhibitor cocktail
(Complete, Mini EDTA free, Boehringer Mannheim) and
incubated on ice for 30min. Thereafter the homogenates
were centrifuged at 13,000 rpm for 30min at +4◦C and
supernatants were collected and stored at −80◦C for MANF and
CDNF ELISAs.
Mouse MANF ELISA
The concentrations of endogenous MANF in mouse tissue
lysates were analyzed by in-lab developed sandwich ELISA. The
development and Validation of the mouse (m)MANF ELISA was
described in detail elsewhere (42). The sensitivity of mMANF
ELISA is 29 pg/ml, and the dynamic range is from 62.5 to 1 000
pg/ml. The ELISA gave no signal from MANF knockout mouse
samples, indicating that it was specific for MANF. Briefly, a 96-
well plate (MaxiSorp, Nunc) was coated with goat antibodies to
MANF (AF3748, R&D+ systems) in carbonate coating buffer (pH
9.6) for overnight at 4◦C. Next day, after washing with PBS-
0.05% Tween (PBST), the wells were blocked with 1% casein in
PBST to prevent unspecific binding. Mouse tissue samples and
recombinant MANF standard were diluted in blocking buffer
and incubated on the plate for overnight at +4◦C. On the third
day, the wells were washed with PBST, and rabbit anti-MANF
antibody (LS-B2688, LSBio) was diluted in blocking buffer and
incubated in the wells for 3 h at 37◦C. For the detection of
bound MANF, a secondary antibody conjugated to horseradish
peroxidase (HRP; NA9340V, GE Healthcare) was applied to the
plate and incubated for 2 h at room temperature. HRP signal was
detected with 3,3′,5,5′-tetramethylbenzidine substrate (DuoSet
ELISA Development System, R&D Systems) and absorbance
measurement using Victor3 reader (Perkin Elmer) at 450 nm and
540 nm (for wavelength correction).
Mouse CDNF ELISA
The levels of endogenous mouse CDNF in mouse tissue
lysates were analyzed by in-lab developed and validated
sandwich ELISA. MaxiSorp (Nunc, Fisher Scientific) 96-
well microtiter plates were coated overnight at +4◦C with
1µg/ml goat anti-mCDNF (AF5187, R&D Systems) in 0.05M
carbonate/bicarbonate coating buffer (pH 9.6). The next day,
unspecific binding to plates was blocked with 3% BSA in PBS for
2 h at room temperature. After blocking, the study and standard
(recombinantmCDNF protein, 5187-CD, R&D Systems) samples
were diluted in the blocking buffer and applied on the plate
as duplicate measurements. The samples were incubated on the
plate overnight at+4◦C in 100 rpm agitation.
Following day, a detection antibody rabbit anti-CDNF (6)
was applied at 0.2µg/ml in blocking buffer, and the plate
was incubated for 3 h at +37◦C in 100 rpm agitation. Finally,
horse radish peroxidase (HRP)-linked donkey anti-rabbit (GE
Healthcare) secondary antibody was diluted at 1:2,000 in
blocking buffer and incubated in the plate for 2 h at room
temperature in 100 rpm agitation. Before each step, liquids from
the previous step were removed, and the wells were washed with
PBS-Tween 20 (0.05%). Blocking and washing were performed in
a volume of 200 µl, while antibodies and samples were added at
100 µl volume. The bound HRP-linked antibody was visualized
by the addition of 3,3′,5,5′-tetramethylbenzidine (DuoSet ELISA
Development System, R&D Systems), and absorbance was read
at 450 and 540 nm (Victor3 reader, Perkin Elmer). MANF and
CDNF concentrations in tissue lysates were normalized to the
total amount of sample protein, which was analyzed by a DC
Protein Assay (Bio-Rad).
Mouse CDNF ELISA was validated for specificity, sensitivity,
dynamic range and precision. Specificity of the assays was
determined by the response to Cdnf −/− tissue lysates. Sensitivity
was determined by the mean absorbance value of ten blank
samples added by 3 standard deviations and calculating resulting
concentration from the standard curve. The dynamic range of
the assay was determined by the accuracy of the back-calculated
concentration values for each standard curve point from six
individual assays. Within the assay dynamic range, the individual
back-calculated accuracy values were within ±10% relative
error (% RE = derived concentration/expected concentration
× 100%) and precision max 10% coefficient of variation (%
CV = SD/mean × 100%). Within-run precision (i.e., intra-
assay variation) was determined by running three samples of
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TABLE 1 | Primary antibodies used in immunohistochemical studies.
Antigen Catolog number Host Dilution Source
MANF 310–100, batch A12ManfPab-005, 0.45 mg/ml Rabbit 1:300 Icosagen, Estonia
ARP (MANF) C-19 sc-34560 Goat 1:500 Santa Cruz
MANF C terminal LS-B2688 Rabbit 1:2000 LSBio
NeuN MAB377 Mouse 1:200 Chemicon
Vasopressin AB1565 Rabbit 1:1000 Millipore
Oxytocin AB911 Rabbit 1:1000 Millipore
ChAT AB144P Goat 1:200 Millipore
GFAP G3893 Mouse 1:500 Sigma
TH MAB318 Mouse 1:200 Millipore
Calbindin D28K (C-20) sc7691 Goat 1:500 Santa Cruz
PGP 9.5 ab10410 Gunia pig 1:500 Abcam
Calcitonin A0576 Rabbit 1:200 Dako, Denmark
GH AFP-5672099 Rabbit 1:600 National Hormone and Peptide
program, Dr. A.F.Parlow
Prolactin AFP-879151 Rabbit 1:600 National Hormone and Peptide
program, Dr. A.F.Parlow
Chromogranin A ab15160 Rabbit 1:400 Abcam
Muc2 (Mucin) SC-15334 Rabbit 1:200 Santa Cruz Biotechnology
Lysozyme A0099 (EC 3.2.1.17) Rabbit 1:1000 Dako
CDNF DDV1 Rabbit 1:1000 (6)
CDNF 5187-CD Rabbit 1:1000 R&D Systems
varying concentration in replicates of ten on different parts of
the same microtiter plate. Between-run precision (i.e., inter-
assay variation) of the assays was determined by running three
samples in duplicate on six independent assay runs performed on
different days. Dilutional linearity and recovery of spiked analyte
were analyzed in the study samples.
The sensitivity of the mouse CDNF ELISA was 6
pg/ml and the dynamic range from 15.6 to 500 pg/ml
(Supplementary Table 1). Intra- and interassay precision
was 10.3% CV (9.0–12.1% CV) and 6.8% CV (4.2–8.7% CV),
respectively (Supplementary Table 2). The assay gave values
below the ELISA sensitivity level for Cdnf−/− tissue samples
(Supplementary Table 3). The linearity of dilution was within
86–106% RE (n = 5, three sequential dilutions per sample,
Supplementary Table 4) and recovery of 100 and 250 pg/ml
spikes of recombinant mouse CDNF was within 85–135% RE
(n= 3 per spike, Supplementary Table 5).
Histological Analysis
Embryonic stem cells were cultured on 0.1% gelatin-coated
dishes in ES cell medium (Knockout DMEMTM high glucose,
Gibco, 10829–018, 15% FBS, 2mMGlutaMaxTM-I (Gibco), 1mM
Non-Essential Amino Acids, 1,000 U/ml LIF and 1µM β-
mercaptoethanol. Cells were fixed in 2% PFA for 1 h, washed
several times with PBS and stained with LacZ staining as
described below. The induction of the Manf gene by reporter
gene β-galactosidase expression was analyzed by LacZ staining
of embryonic stem cells and whole mount staining of embryonic
day (E)7.5 decidua and E9.5 embryos. Immunohistochemistry
(IHC) was applied for sectioned E9.5 and E13.5 embryos, and
adult mouse tissues.
LacZ staining on whole mount embryos was performed on
deciduae containing E7.5 embryos using X-gal solution. First,
the removed deciduae were fixed in 2% PFA for 1 h on ice
and washed several times in PBS at RT for 2 h. Thereafter
deciduae were incubated in staining solution [PBS supplemented
with 2mM MgCl2, 5mM potassium ferrocyanide (K4Fe(CN)6-
3H20], 5mM potassium ferricyanide [K3Fe(CN)6, 0.01% NP-
40, 0.01% Sodium deoxycholate] containing X-Gal reagent
(5-Bromo-4-chloro-3-indolyl beta-D-galactopyranoside) at final
concentration of 1 mg/ml for several hours at 37◦C in dark. After
staining, deciduae were dehydrated and embedded in paraffin
followed by sectioning of the samples and counterstaining with
nuclear fast red.
For IHC the animals were euthanized by carbon dioxide
followed by cervical dislocation. Mouse tissues or embryos
were collected and fixed in 4% paraformaldehyde (PFA) for
72 h following embedding to paraffin. Deparaffinised 5µm thick
sections were boiled in citrate buffer pH 6.0 for retrieval of
the antigen, rinsed in Tris-buffered saline (TBS) (pH 7.4) and
kept in 0.3% H2O2 solution for 30min to suppress endogenous
peroxidase activity. Next, the sections were washed in TBS with
0.1% Tween (TBST) and blocked with 5% goat or 5% donkey
serum for 1–2 h at room temperature. Samples were incubated
with primary antibodies (Table 1) in the appropriate blocking
buffer overnight at 4◦C. For light microscopy peroxidase
staining, sections were incubated with biotinylated secondary
antibodies for 1 h at room temperature, washed in TBST
and incubated with avidin-biotinylated enzyme complex (ABC)
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according to manufacturer’s instructions. Finally, after the
washing procedure in TBST, samples were developed with 3,
3’-Diaminobenzidine (DAB), counterstained with hematoxylin
and mounted with Depex. For immunofluorescence staining,
sections were subjected to antigen retrieval and incubated
with primary antibody o/n, followed by incubation with
appropriate Alexa-conjugated secondary antibodies, for 4 h at
room temperature, washed in TBST andmounted withmounting
medium containing DAPI (Vectashield, Vector Laboratories,
Burlingame, CA, USA) to visualize nuclear staining.
Importantly, anti-MANF antibodies have been validated by
using Manf−/− tissues. No background was detected in the
tissues ofManf−/− mice (Supplementary Figures 1H–J, 3A–M).
Statistical Analysis
All data are presented as mean ± SEM. Statistical significance
was assessed via Student’s t-test between 2 groups as mentioned
in the figure texts using GraphPad Prism 6 software (GraphPad
Software, Inc., La Jolla, CA).
RESULTS
MANF Expression During Embryonic
Development in Mice
Manf mRNA expression has previously been analyzed by in
situ hybridizations in E12.5 mouse embryos (39). Here we
analyzedManf gene expression in early embryonic development
using staining for LacZ enzymatic activity of Manf+/− embryos
containing a β-galactosidase reporter gene (lacZ), which is
controlled by the endogenous MANF promoter (16). We found
LacZ staining indicating MANF expression in targetedManf+/−
embryonic stem cells (ESC) (Supplementary Figures 1A,B).
During early embryogenesis, LacZ staining was detected
in E7.5 Manf+/− embryos. LacZ negative decidual cells
embedding the embryo are originating from the Manf+/+
mother (Figures 1A–D). Positive LacZ staining was detected in
most cells of all three germ layers—ectoderm, endoderm and
mesoderm in the E7.5 embryo (Figures 1A–D). Notably, no
LacZ staining was detected in extraembryonic ectoderm, which
contributes to the formation of the placenta (Figures 1A–D).
In order to analyze MANF expression pattern in mouse
tissues, we used highly specific MANF antibodies, which we
validated on Manf knockout tissue as a control for a negative
signal. No background was detected in the tissues fromManf−/−
mice (Figures 1F,H,J, Supplementary Figures 1C–H, 3A–M).
Next, we studied the expression of MANF in E9.5 Manf+/+
and Manf−/− embryos by IHC. Within the neural tube,
MANF expression was observed in the regions forming the
forebrain, midbrain, and hindbrain (Figure 1E). Outside the
nervous system, MANF immunoreactivity cells were detected
in somites giving rise to the dermis, skeletal muscles, and
vertebrae (Figures 1E,G). MANF expression was also found
in the developing heart, mandibular component of the first
branchial arch and in the origin of second and third branchial
arches in the E9.5 embryo (Figure 1E). The same positive
signal was observed by LacZ in E9.5 heterozygous Manf+/−
mouse embryo (Supplementary Figures 1C,D). No staining was
detected inManf−/− embryos (Figure 1F).
MANF was widely expressed in Manf+/+ embryos at
E13.5 when many of the CNS and peripheral nervous system
(PNS) structures, as well as other peripheral tissues, begin
to differentiate (Figure 1I, Supplementary Figures 1E–G). In
agreement with our previous in situ hybridization results,
within the CNS, MANF immunostaining was observed in the
neocortex, striatum, midbrain, hypothalamus and spinal cord
(Figures 1I,K–P). High levels of MANF immunoreactivity was
detected in the choroid plexus, the lumen of Rathke’s pouch
(Figure 1Q), an ectodermal structure forming the anterior
pituitary gland, and vestibulocochlear ganglion (Figure 1R).
In the PNS, MANF was highly expressed by neurons in
trigeminal (Figure 1S) and dorsal root ganglia (Figure 1T).
MANF immunoreactive cells were also observed in the
developing peripheral tissues such as heart, lung, liver, intestine
and developing pancreas (Figures 1U–Y) (5).
Differential Expression Levels of MANF and
CDNF in Adult Mouse Tissues
Our previous studies have demonstrated the wide distribution
of Manf mRNA expression in the adult mouse brain by in situ
hybridization, as well as protein expression in the adult cortex,
hippocampus, cerebellum, striatum, and substantia nigra and
non-neuronal tissues (39).
In this study, we analyzed and compared the levels of MANF
and CDNF mRNA and protein expression in a broad panel of
different tissues from adult mice using RT-qPCR and ELISA.
Highest levels ofManf mRNA were observed in pituitary glands,
endocrine islets of Langerhans, in the pancreas exocrine tissue
separated from islets using collagenase digestion, and testis
(Figure 2A) (5). Moderate levels ofManf mRNA expression was
detected in ovary, heart, liver, and parts of intestine including
duodenum and jejunum compared with low levels in the adrenal
gland, brain, thymus, lung, salivary gland, kidney, spleen, ileum,
colon, and muscle (Figure 2A).
Next, we analyzed the MANF protein expression by mouse
MANF ELISA developed in our laboratory (42). In accordance
with Manf mRNA levels, the highest concentrations of MANF
protein was observed in pancreas and testis (Figure 2B). The
MANF concentration in the pancreas was 894± 154 ng/mg total
protein (n= 3), and in the testis 1,170± 168 ng/mg total protein
(n = 4), respectively, indicating that MANF corresponds to ∼1
promille of all proteins in these tissues. MANF concentration in
the pituitary gland, liver, and salivary gland was between 300 and
400 ng/mg total protein, which is ∼3 times lower compared to
the MANF levels in testis and pancreas.
In the brain, brown adipose tissue, spleen, kidney, ovary,
and thymus MANF protein concentration varied between 100
and 250 ng/mg total protein. The lowest MANF protein
concentrations were found in skeletal muscle (82± 6 ng/mg total
protein, n= 4), white adipose tissue (67± 4 ng/mg total protein,
n = 3) and heart (38 ± 2 ng/mg total protein, n = 4). Protein
concentration was almost 3-fold in brown adipose tissue (199 ±
14 ng/mg total protein, n= 4) compared to white adipose tissue.
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FIGURE 1 | LacZ staining and MANF immunohistochemistry on sections from mouse embryos at E7.5, E9.5, and E13.5. (A–D) Positive LacZ staining observed in
mesoderm (me), ectoderm (ec), and endoderm (en) layers of developing E7.5 heterozygous Manf+/− mouse embryo. No positive LacZ staining was observed in
extraembryonic ectoderm (exec). (E–H) MANF expression in developing E9.5 embryo (E). MANF antibody did not stain E9.5 Manf −/− embryos, indicating high
(Continued)
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FIGURE 1 | specificity of the used anti-MANF antibody (F). MANF staining detected in the somites of E9.5 Manf +/+ embryos (G). No positive staining detected in
Manf −/− somites (H). Scale bar 500µm (E,F). Scale bar 20µm (G,H). dev. heart, developing heart; FBA, first branchial arch. (I) MANF expression in E13.5 mouse
embryo with indicated anatomical structures. Scale bar 1,000µm. No MANF positive signal was detected in E13.5 Manf −/− embryo (J). Scale bar 1000µm.
(K) MANF antibody staining in the developing E13.5 cortex (CTX). (L) Strong MANF expression was detected in choroid plexus. MANF staining in developing striatum
(STR) (M), midbrain/pons junction (Mb) (N), peduncular and terminal hypothalamic areas (Phy, Thy) (O,P). Strong expression of MANF in the lumen of Rathke’s pouch
(Q), vestibulocochlear ganglion (R), trigeminal ganglia (S), dorsal root ganglia (DRG) (T). MANF expression in developing mouse heart (U), developing mouse lung (V),
developing mouse gut (W), developing mouse liver (X). MANF expression in the developing pancreatic primordium (Y). Scale Bar for 20µm (K,M-P,X). Scale Bar
50µm for (L,R,T,V,W,Y).
Highest levels of Cdnf mRNA were found in the muscle,
heart and exocrine tissue of pancreas by RT-qPCR (Figure 2C).
Moderate levels of Cdnf mRNA expression were detected in
pituitary gland and testis (Figure 2C). Low levels of Cdnf mRNA
was observed in the other tissues studied (Figure 2C). Thus, the
expression levels and tissue distribution of Manf mRNA differs
from Cdnf mRNA in mouse tissues.
Consistent with Cdnf mRNA levels, highest levels of CDNF
protein were observed in the skeletal muscle (19.2 ± 1.5 ng/mg
of total protein, n= 4), heart (18.8± 1.4 ng/mg total protein, n=
4) and testis (10.8± 1.4 ng/mg total protein, n= 4) (Figure 2D).
Interestingly, we observed high levels of CDNF protein also in
brown adipose tissue (11.9 ± 0.4, ng/mg of total protein, n
= 4). However, the median difference in CDNF and MANF
concentration was ∼125-fold in favor of MANF. The highest
difference between MANF and CDNF concentrations was found
in the pancreas (MANF vs. CDNF concentration 10 341x), liver
(3 015x) and salivary gland (1 153x). In these tissues CDNF
concentration was lowest measured (i.e., pancreas 0.09 ± 0.02
ng/mg total protein, n= 2; liver 0.12± 0.02 ng/mg total protein,
n = 4; and salivary gland 0.28 ± 0.04 ng/mg total protein, n
= 4, respectively). The smallest difference between MANF and
CDNF concentrations was found in the heart (MANF vs. CDNF
concentration 2.0 x), skeletal muscle (4.3x) and thyroid gland
(4.5x). In these tissues, CDNF protein concentration was highest
measured, while MANF concentration was at the lower end.
MANF Expression in Structures of the
Central and Peripheral Nervous Systems
Responsible for Metabolism, Energy
Homeostasis, and Hormonal Regulation
The MANF protein expression pattern in the brain was studied
using MANF antibody staining. Our results are consistent with
our previous in situ Manf mRNA hybridization studies on P10
and adult mouse brain (39, 40). In this study, we analyzed in
detail the expression of MANF in the juvenile brain of 2 week-
old mice using MANF IHC. We observed MANF expression
in all brain regions in the P14 mouse brain (Figures 3A–D,
Supplementary Figures 2A–BB, Supplementary Text).
The hypothalamus is a key area of the brain known for the
regulation of food intake, energy balance, and the coordination
of the peripheral endocrine system through the pituitary gland
(43, 44). Consistent with previous studies (5, 33, 39, 40),
abundant expression of MANF was detected in different
hypothalamic regions responsible for the hormonal regulation
via adenohypophysis of the pituitary gland such as medial
preoptic area (MPO) (Figure 3C) (release of gonadotrophin-
releasing hormones), paraventricular hypothalamic nuclei
(PVN) (Figure 3D) (secretion of somatostatin, growth-
hormone-inhibiting hormone, corticotropin-releasing hormone,
thyrotropin-releasing hormone), arcuate hypothalamic nucleus
(ARC) (Figure 3G) (responsible for the secretion of growth
hormone-releasing hormone and dopamine-mediated prolactin
inhibition) and median eminence (functional link between the
hypothalamus and pituitary gland) (Figure 3G). Magnocellular
neurons of the PVN and supraoptic nuclei (SON) (Figure 3E)
parts of hypothalamus are also responsible for the production of
oxytocin and vasopressin that are released to the bloodstream
via neurohypophysis of the pituitary gland. In this study
we identified that MANF is co-expressed with oxytocin and
vasopressin positive neurosecretory cells in the PVN and SON
nuclei of the hypothalamus (Figures 3S–X), suggesting that
proper amount of MANF expression may be needed for cells
regulating processes such as sexual behavior, social recognition,
stress response, depression, aging, and water balance of the body.
We also detected high MANF-expression in hypothalamic
nuclei that are important for appetite, feeding and energy
expenditure including ARC (contains appetite-stimulating
(orexigenic neuropeptide Y and agouti-related peptide-
expressing neurons) and appetite-suppressing neurons
[anorexigenic pro-opiomelanocortin (POMC)-expressing
neurons] (45), PVN, DMH (Figure 3F), LH and VMH
(Figure 3H).
Another key brain structure involved in the regulation of
food intake is the brainstem. We identified high levels of MANF
expression in the locus coeruleus (LC) nucleus (Figure 3M),
dorsal nucleus of the vagus nerve (DMNX) (Figure 3R), rostral
ventrolateral medulla (RVLM) (Figure 3O) and low levels
in parabrachial nucleus (PBN) (Figure 3N), area postrema
(AP) (Figure 3P), sensory nucleus of the solitary tract (NTS)
(Figure 3Q). Additionally, MANF expression was detected
in circumventricular organs, such as the subcommissural
organ (SCO) (Supplementary Figure 2L). Importantly, we
detected MANF expression in choline acetyltransferase positive
motor neurons of the dorsal nucleus of the vagus nerve
(Figures 3Y–AA), which are known for their role in the
regulation of gastrointestinal tract secretion, motility and in
mediating pancreatic secretion (46).
In addition, the brain reward system is implicated in
the control of hedonic feeding regulated by the mesolimbic
and mesocortical dopaminergic pathways. Moderate expression
levels of MANF was observed in the medial prefrontal cortex
(mPFC) (Figure 3I), nucleus accumbens (NAc) (Figure 3J),
Frontiers in Endocrinology | www.frontiersin.org 7 November 2019 | Volume 10 | Article 765
Danilova et al. MANF Expression in Metabolic Tissues
FIGURE 2 | MANF and CDNF mRNA and protein expression in mouse brain and non-neuronal tissues. (A) RT-qPCR analysis of Manf mRNA expression in adult
mouse brain and non-neuronal tissues. n-numbers for pituitary gland = 7, adrenal gland = 5, pancreases for islets = 8, pancreases for exocrine tissue, ovary, brain,
lung, spleen, duodenum, jejenum, ileum, colon, muscle = 3, testis, heart and liver) = 4, thymus = 6. (B) Quantification of MANF protein in mouse tissues using mouse
ELISA analysis, ng/mg total protein. n- numbers for pituitary gland, adrenal gland, testis, ovary, brain, thymus, heart, liver, salivary gland, kidney, brown adipose tissue
and muscle) = 4, and for pancreas, spleen, and white adipose tissues) = 3. (C) RT-qPCR analysis of Cdnf mRNA expression in adult mouse brain and non-neuronal
tissues. n-numbers for pituitary gland = 7, adrenal gland = 5, pancreases for islets = 8, pancreatic exocrine tissue, ovary, brain, lung, spleen, duodenum, jejenum,
ileum, colon and muscle = 3, testis, heart and liver = 4, and thymus = 6. (D) CDNF mouse ELISA protein analysis in mouse tissues, ng/mg total protein. n-numbers
for pituitary gland, adrenal gland, testis, ovary, brain, thymus, heart, liver, salivary gland, kidney, brown adipose tissue, and muscle = 4, pancreas, spleen, and white
adipose tissue) = 3.
paraventricular nucleus of the thalamus (PVT) (Figure 3K),
and ventral tegmental area (VTA) (Figure 3L). We identified
that MANF positive cells are co-expressed with tyrosine
hydroxylase (TH)-positive dopamine neurons in the VTA
(Figures 3BB–DD).
Neurons of hypothalamus make projections onto neurons
within the medulla that in turn project via the spinal cord
through intermediolateral column (IML) to connect with the
autonomic nervous system (ANS), thereby regulating heart rate,
respiration, brown adipose tissues (BAT)/thermogenesis, and
white adipose tissue (WAT) to modulate energy state. MANF
expression was detected in neuronal bodies in the dorsal and
ventral horns of the adult mouse spinal cord at P56 (Figures 4A–
E). We also detected high MANF immunoreactivity in the IML
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FIGURE 3 | Immunohistochemical analysis of MANF expression in the mouse brain at postnatal day P14. (A) Low magnification of the mouse brain coronal sections
stained with MANF antibody. (A) Scale bar 1,000µm. No positive staining detected in Manf −/− mouse brain (B). OLF, Olfactory bulb; CTX, cortex; STR, striatum; Hip,
(Continued)
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FIGURE 3 | hippocampus; Tha, thalamus; Snc, substantia nigra pars -compacta; Cb, cerebellum. MANF expression was detected in most brain areas, with strong
expression in homeostatic and hedonic control centers such as hypothalamus, dopamine mesolimbic system, and brainstem structures and neuroendocrine
hypothalamic centers coordinating the hypothalamic pituitary endocrine axes. (C–H) Strong expression of MANF was detected in different parts of anterior and tubelar
hypothalamus. (C) Medial preoptic nucleus (MPO). Scale bar 50µm. (D) Paraventricular nuclei (PVN). Scale bar 100µm. (E) Supraoptic nuclei. Scale bar 100µm.
(F) Dorsomedial hypothalamic nucleus (DMH). Scale bar 50µm. (G) Medial eminence (ME) and arcuate nuclei (ARC). Scale bar 50µm. (H) Ventromedial nuclei (VMH).
Scale bar 50µm. (I–L) MANF expression in dopamine mesolimbic system. (I) MANF expression in the medial prefrontal cortex (mPFC), Scale bar 100µm. (J) Nuclei
accumbens (Nac). Scale bar 50µm. (K) MANF expression in paraventricular nucleus of the thalamus (PVT). Scale bar 50µm. (L) Ventral tegmental area (VTA). Scale
bar 20µm. (M–R) MANF exression in the brainstem structures of the mouse brain. (M) Locus coeruleus (LC). Scale bar 50µm. (N) Parabrachial nucleus (PBN). Scale
bar 50µm. (O) Rostral ventrolateral medulla (RVLM). Scale bar 20µm. (P) Area postrema. Scale bar 20µm. (Q) Nucleus of the solitary tract (NTS). Scale bar 20µm.
(R) Dorsal motor nucleus of Vagus (DMV). Scale bar 20µm. (S–DD) Double immunohistochemistry analysis with anti-MANF antibody and antibodies against other
peptide hormone and neuronal markers. MANF positive cells (S,V,Y,BB) were co-expressed with antidiuretic hormone vasopressin (green) (T) in supraoptic
hypothalamic nucleus (U) and oxytocin (green) (W) in paraventricular hypothalamic nuclei (X), with choline acetyltransferase positive neurons (ChAT) (red) (Z) in the
dorsal motor nucleus of vagus (AA), with tyrosine hydroxylase (green) (TH) (CC) positive neurons in ventral tegmental area (DD). Cell nuclei were labeled with DAPI
(blue). Scale bar, 20µm.
nucleus (Figure 4C) of the spinal cord. MANF positive staining
was observed in glial cells of the gray matter (Figure 4D) and
in the myelinated axons of the white matter (Figure 4E). Very
strong expression of MANF was detected in motor neurons and
their dendrites immuno-labeled with choline acetyltransferase
(Figures 4F–H) and neuronal and neuroendocrine protein gene
product 9.5 (PGP9.5) markers (Figures 4I–K).
In the adult PNS, strong expression of MANF was observed
within the sensory neuronal bodies of adult dorsal root
ganglia (DRG) (Figures 4L–N) and in sympathetic celiac ganglia
(CLG) (Figures 4U–W). BAT thermogenesis is regulated by a
negative feedback loop via the DRG sympathetic nervous system
stimulation (47). CLG is a part of the ANS which innervates
most of the digestive tract, liver, and pancreas, thereby regulating
their functions. Similarly to the spinal cord, only neuronal bodies
were positive for MANF and not nerve fibers in DRG and CLG
(Figures 4O–T,X–Z,AA–CC).
Characterization of MANF Expression in
the Mouse Endocrine System
The endocrine system consists of the hypothalamus, pituitary
gland, pineal body, thyroid and parathyroid glands, adrenal
glands, and the reproductive organs (ovaries and testes).
These glands secrete hormones to the blood circulation, which
control cellular and organ growth, development, metabolism,
reproduction, sleep, and response to stress stimuli among
others. Incorrect amount of hormone production leads to
medical conditions such as insulin-deficiency in Type 1 diabetes,
growth hormone-deficiency in postnatal growth defects caused
by hypopituitarism and hormonal dysregulation in metabolic
syndrome (43, 48, 49). Our qPCR and ELISA results for
MANF expression showed that MANF is highly expressed in
mouse endocrine tissues such as the pituitary gland, the thyroid
gland, pancreatic islets and testis as well as exocrine tissues
such as exocrine pancreas, salivary glands and other tissues
containing cells with secretory function (Supplementary Text
and Supplementary Figure 4) compared to the rest of the
tissues (Supplementary Text and Supplementary Figures 5, 6).
Therefore, we studied the cellular distribution of MANF
expression by IHC in different juvenile and adult mouse
endocrine organs (Figure 5). In the adult mouse pituitary gland,
strong MANF immunoreactivity was observed in most cells
of the endocrine anterior adenohypophysis (Figures 5A,B) and
the intermediate lobe (Figures 5A,C) as well as in cells of
the neurohypophysis (Figures 5A,D). Additionally, we found
strong MANF expression in the thyroid follicular cells producing
thyroxine (T4) and triiodothyronine (T3) (Figures 5E,F). MANF
was also co-expressed with calcitonin in parafollicular C-cells,
responsible for reducing calcium levels in the blood by inhibiting
osteoclast activity in bones and inhibiting renal reabsorption
(Figures 5H–J). MANF immunoreactivity was strong also in
parathyroid glands (Figures 5E,G), that is responsible for the
production of parathyroid hormone and thereby regulation of
calcium and phosphate levels in the blood. In the adrenal gland,
in contrast to moderate and low levels of MANF mRNA and
protein detected by RT-qPCR and ELISA (Figures 2A,C), intense
MANF staining was detected in the cortex and less in the medulla
(Figure 5K). Furthermore, MANF was co-expressed with TH
in the medullar chromaffin cells, responsible for the synthesis
and release of catecholamine, adrenaline, and noradrenaline, in
response to stress (Figures 5L–N).
In the mouse reproductive system, we observed MANF
expression in the mouse ovaries and ampullas of the Fallopian
tubes (Figures 5O–Q). MANF expression was detected in
granulosa or cumulus cells, which surround and nourish the
oocytes in the ovary (Figure 5P). Additionally, we detected
MANF expression in male seminiferous tubules of the mouse
testis at P14 (Figure 5R).
Ablation of MANF Expression in Manf −/−
Mice Leads to Defects in the Anterior
Pituitary Gland
The phenotype of Manf−/− mice is characterized by the
progressive loss of circulating insulin leading to diabetes and a
severe growth defect (16). We have previously demonstrated that
the dramatic growth retardation in conventional Manf−/− mice
is not dependent on the diabetic phenotype as the growth defect
is not recapitulated in the pancreas-specific Pdx-1Cre::Manffl/fl
mice, that develop diabetes but no growth retardation (16). In
addition, neuron-specific NestinCre+/−::Manffl/fl mice do not
develop an equally severe growth defect compared to global
Manf−/− mice [(16); Pakarinen et al. submitted manuscript].
Short stature or dwarfism is usually caused by a pituitary growth-
hormone deficiency in humans (50). Thus, the short stature of
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FIGURE 4 | MANF expression in the mouse spinal cord and celiac ganglia at the postnatal day P56. (A) Low magnification of the mouse spinal cord coronal sections
stained with MANF antibody. Scale bar, 200µm. (B) Strong MANF expression was detected in neurons in the ventral horn of gray matter. (C) MANF expression in the
neurons of intermediolateral column (IML) nucleus in dorsal horn of gray matter. (D) MANF expression in neurons in the central canal of gray matter. (E) Low
(Continued)
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FIGURE 4 | expression of MANF was detected in the cells of white matter. (B,C) Scale bar, 20µm. (F–H) Double immunohistochemistry analysis with anti-MANF
(F) and choline acetyltransferase positive neurons (ChAT) antibodies (G). MANF (green) was co-expressed with Vacht in motor neurons (red) in the ventral horn of gray
matter (H). MANF (green) was co-localized with PGP9.5 (red)-stained neurons in the ventral horn of gray matter (K). (F–K) Scale bar, 20µm. Cell nuclei were labeled
with DAPI (blue). (L) Low magnification of the mouse dorsal root ganglia stained with MANF antibody. Scale bar, 100µm. (M) Strong MANF immuno-reactivity was
observed in the neuronal bodies. Scale bar, 20µm but only few cells MANF-positive cells were detected in the nerve bundles of dorsal root ganglia (N). Scale bar,
20µm. (O–T) Double immunohistochemistry analysis with anti-MANF (O,R) and PGP9.5 antibodies (P,S). MANF (green) was co-expressed with PGP9.5 (red) in
neuronal bodies (Q), but only scarce MANF expression was detected in the nerves of the celiac ganglia (T). (O–T) Scale bar, 20µm. (U) Low magnification of the
mouse celiac ganglia stained with MANF antibody. Scale bar, 50µm. (V) Strong MANF expression was observed in the neuronal bodies. Scale bar, 20µm. (W)
Negative MANF expression in the nerves of celiac ganglia. Scale bar, 20µm. (X–Z) Double immunohistochemistry analysis with anti-MANF antibody (X,AA) and
PGP9.5 positive neurons (Y,BB). MANF (green) was co-expressed with PGP9.5 (red) positive neuronal bodies (Z), but MANF expression was not detected in the
nerves of the celiac ganglia (CC). (X–CC) Scale bar, 20µm.
Manf−/− mice and the high MANF expression in the pituitary
gland prompted us to study the pituitary gland in more detail in
theManf−/− mice.
The pituitary gland plays crucial roles in growth,
reproduction, endocrine functioning, and functions to convey
signals from the hypothalamus to various organs (43, 51).
The endocrine anterior pituitary gland contains five types of
cells, each secreting different hormones, where somatotropes
secrete growth hormone (GH), lactotropes prolactin (PRL),
gonadotropes follicle stimulating hormone (FSH) and luteinizing
hormone (LH), corticotropes adrenocorticotropic hormone
(ACTH), and thyrotropes thyroid-stimulating hormone (TSH)
(43). We stained sections from the pituitary glands with
hematoxylin-eosin for morphological analysis (Figures 6A,B).
This revealed that the size of the adenohypophysis in Manf−/−
mice was reduced compared to the adenohypophysis from
Manf+/+ mice in relation to body weight at 6 weeks of age
(Figure 6E), while the area of the intermediate lobe was not
changed between the groups (Supplementary Figure 7A)
and the area of neurohypophysis was increased in Manf−/−
mice compared to control (Supplementary Figure 7B). The
ratio of granule-filled acidophilic cells (purple) representing
somatotropes and lactotropes (Figures 6C,D) compared to
basophils (blue) were significantly reduced in the anterior
lobe of 6-week-old Manf−/− mice compared to Manf+/+ mice
(Figure 6F). Double immunofluorescence staining revealed
co-localization of MANF with growth hormone (Figures 6G–I)
and prolactin (Figures 6J–L) in cells of the anterior pituitary
lobe at 6 weeks of age.
Immunoperoxidase staining of the pituitary glands revealed
decreased GH (Figure 6N) and PRL (Figure 6P) expression
in the adenohypophyses of the Manf−/− mice compared to
Manf+/+ mice (Figures 6M,O). Quantification of the ratio of
GH- and PRL-positive cells in the adenohypophyses confirmed
a severely reduced number of GH (Figure 6Q) and PRL
(Figure 6R) producing cells in Manf−/− mice compared to
that of Manf+/+ mice. In line with the reduced size of
the adenohypophysis in Manf−/− mice, we found a clear
reduction in the number of proliferative cells (Figure 6S,
Supplementary Figures 7C,D) but no increase in the number of
dying cells (Supplementary Figure 7E) in the adenohypophyses
ofManf−/− mice.
Consistent with the reduced number of GH and PRL positive
cells, mRNA expression levels of Gh and Prl (Figure 6T)
genes were significantly decreased in the pituitaries isolated
from Manf−/− mice compared to those of Manf+/+ mice
regardless of gender. The levels of pro-opiomelanocortin
(Pomc) mRNA and Thyroid-stimulating hormone (Tsh)
mRNA were significantly increased in Manf−/− pituitaries
(Figure 6T), probably reflecting the higher relative number
of corticotropes and thyrotropes in the Manf−/− pituitaries.
In accordance with the essential role of the pituitary-specific
positive transcription factor 1 (Pit1) for the development of
somatotropes and lactotropes, we observed that Pit1 mRNA
expression was significantly downregulated in the Manf−/−
mutant pituitary glands (Figure 6T). Both mRNA levels for
luteinizing hormone (Lh) and follicle-stimulating hormone (Fsh)
were non-significantly downregulated in the pituitaries of 6
weeks old Manf−/− male mice compared to Manf+/+ controls
(Figures 6U,V), while Fsh mRNA levels were significantly
upregulated and Lh mRNA was not affected in pituitaries of
Manf−/− female mice.
As chronic ER stress precedes the reduced pancreatic β-cells
proliferation and increased β-cells death leading to diabetes in
Manf−/− mice (16), we investigated whether ablation of MANF
from the pituitary leads to ER stress and chronic UPR activation.
Importantly, we found significant upregulation of UPR genes
representing all three main UPR pathways PERK, IRE1α, and
ATF6 in the pituitaries isolated from 6 week-old Manf−/− mice
indicating that chronic ER stress may be a cause of the acidophilic
cell loss in the pituitary glands ofManf−/− mice (Figure 6W).
Hence, these results suggest that MANF expression is needed
to support the GH and PRL expressing cells in the anterior
pituitary of mice.
DISCUSSION
In summary, this study provides a systematic analysis of
MANF expression in mouse tissues with a focus on neuronal
and peripheral tissues, including cells with high metabolic,
and secretory function by different techniques. We provide
a comparative analysis of MANF and CDNF mRNA and
protein expression in postnatal mouse tissues (Tables 2, 3).
The strength of our expression analysis lies in the validation
of the specificity of the techniques using tissue-samples from
Manf−/− and Cdnf−/− mice. In addition, we have confirmed the
reporter β-galactosidase expression under the Manf promoter
in tissues of heterozygote and homozygote Manf+/− and
Manf−/− mice using X-gal staining. Importantly, we report
a novel pituitary gland phenotype in the MANF-deficient
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FIGURE 5 | MANF expression in the mouse endocrine system. (A) Sagittal section of mouse pituitary gland at postnatal stage P56 stained with MANF antibody. Scale
bar, 100µm. (B) Strong MANF expression was observed in the adenohypophysis. Scale bar, 20µm. (C) Strong MANF expression was observed in intermediate lobe
(Continued)
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FIGURE 5 | of mouse pituitary gland. Scale bar, 20µm. (D) Low expression of MANF was detected in the neurohypophysis. Scale bar, 20µm. (E) Transversal section
of the mouse thyroid gland at postnatal stage P14 stained with MANF antibody. Scale bar, 200µm. (F) Strong MANF expression was observed in the follicular
epithelium of the thyroid gland. Scale bar, 20µm. (G) Strong MANF expression was detected in parathyroid gland. Scale bar, 50µm. (H–J) Double
immunohistochemistry analysis on thyroid section with anti-MANF (H) and anti-calcitonin (I) antibodies. Scale bar, 20µm. MANF (red) was co-expressed with
calcitonin (green) in C-cells (J). (K) Strong MANF expression was detected in the cortex and moderate levels of MANF was observed in the medulla of mouse adrenal
gland at postnatal stage P14. Scale bar, 50µm. (L–N) Double immunohistochemistry analysis with anti-MANF antibody (L) and anti-TH (M) antibodies. MANF (red)
was co-expressed with TH (green) in the medullar cells of the mouse adrenal gland (N). Scale bar, 20µm. (O) Low magnification of the mouse ovary at postnatal
stage P14 stained with MANF antibody. Scale bar, 200µm. (P) Strong MANF expression was observed in the granulosa cells surrounding the oocyte. Scale bar,
20µm. (Q) Strong MANF expression was observed in the ampulla. Scale bar, 50µm. (R) Strong MANF expression was detected in seminiferous tubules of the mouse
testis at postnatal stage P14. Scale bar, 50µm.
mice, which might contribute to the severe postnatal growth
defect. We are the first to report MANF expression in mouse
embryonic stem cells, as well as in all three germ layers
during mouse gastrulation. This it is not surprising since
MANF is ubiquitously expressed in most developing organ
systems in the embryo and through adulthood. In the postnatal
CNS, MANF expression was very high in the cells of the
various areas that regulate energy metabolism and the endocrine
system including the mesocortical/mesolimbic dopamine system,
different areas of hypothalamus, and brainstem structures of
the mouse brain. In a recent study, increased expression of
MANF in hypothalamic neurons of mice led to increased feeding
behavior and obesity, whereas reduced expression specifically
in hypothalamic neurons led to hypophagia and reduced
body weight (33). The mechanism behind MANF action was
suggested to rely on its ability to regulate insulin signaling
by interacting with phosphatidylinositol 5-phosphate 4-kinase
type-2 beta (PIP4K2B) in the ER and thus regulating AKT
phosphorylation and insulin sensitivity (33). In addition, reduced
MANF expression in tissues and sera of mice led to increased
liver inflammation, fibrosis, and steatosis whereas MANF
supplementation seemed to reverse age-dependent inflammatory
and metabolic changes and induce rejuvenation in mice (34). In
the fruit fly, overexpression ofMANF in cells of peripheral tissues
led to a significant extension of life-span, whereas overexpression
of MANF in the brain led to reduced life-span (34). These results
suggest that proper regulation of MANF expression in the brain
and other organs is important to meet the metabolic demand.
Thus, the exact mechanism of MANF action in metabolic
regulation remains to be elucidated.
In previous studies by us and others it has been demonstrated
that MANF is highly expressed in secretory tissues including
mouse and human pancreatic exocrine acinar cells and β-cells
of Langerhans islets and mouse salivary gland and testis (4,
5, 16, 39, 52). In this study, we show for the first time that
MANF is highly expressed also in the tissues of mouse endocrine
system such as in the pituitary, thyroid, parathyroid, and adrenal
glands as well as in the mouse female reproductive system.
We found strong expression of MANF in the thyroid follicular
and para-follicular cells that produce vital hormones for all
body functions. Histologically the thyroid gland in theManf−/−
mice appears normal (Danilova, Lindahl, unpublished results).
However, it remains to be determined whether the circulating
levels of calcitonin, T4 and T3 and parathyroid hormone are
reduced in MANF-deficient mice, which could, in addition to
diabetes contribute to the retarded growth and reduced life-span
inManf−/− mice (16).
In the mouse adrenal gland, MANF expression was high in
cells of the zona glomerulosa of the cortex that is responsible
for the production of mineralocorticoids such as aldosterone.
In accordance, high levels of MANF was found in cells of
the juxtaglomerular apparatus in the mouse kidney, indicating
that MANF expression levels could be important for the
proper function of the renin-angiotensin–aldosterone hormonal
system required for control of the blood pressure and sodium
homeostasis. High MANF expression was also found in cells
producing glucocorticoids, which increase glucose production
from amino acids in the liver and increase the anti-inflammatory
response. In addition, MANF was expressed in the adrenal zona
reticularis, which produces androgens that are converted to sex
hormones in the gonads. In accordance, strong expression of
MANF was observed in the female and male mouse reproductive
organs. In the female uterine tube, high MANF expression was
observed in the epithelium of the fallopian tubules. In addition,
MANF was highly expressed by granulosa cells, especially in
cells surrounding some oocytes, suggesting that MANF levels
are increased with oocyte maturation. In addition, MANF was
highly expressed in differentiating spermatocytes in the mouse
seminiferous tubules in the testes. Consistent with our mouse
studies, the Manf-1 gene was activated in the spermatheca of
transgenic C. elegans (53). Interestingly, MANF-deficient C.
elegans displayed fewer offspring due to fewer fertilized eggs
being laid than their wild type littermates (53, 54). Additionally,
in vitromaturation procedure led to enhancedMANF expression
levels in the mouse oocytes (55), possibly due to the stress
caused by the procedure. The heterozygous Manf+/− female
and male mice are fertile and breed normally (16). However,
diabetic female andmaleManf−/−mice do not produce offspring
suggesting that they are infertile (Lindahl, personal observation).
Therefore, MANF expression might be needed for the highly
metabolic action of cells in both female and male mouse fertility
processes. The mechanism of MANF action in the mouse
reproductive system remains to be studied. To conclude, the
pattern and level of MANF expression in the neuroendocrine and
endocrine mouse systems suggest important roles for MANF in
cells with a high level of hormonal secretory function within the
hypothalamus-pituitary-thyroid/adrenal/gonadal axes.
We compared the MANF expression pattern and levels
observed in mouse tissues with the expression data found from
human tissue in the Human Protein Atlas database (https://www.
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FIGURE 6 | Ablation of MANF in the conventional Manf −/− mice results in abnormal development of the adenohypophysis in the pituitary gland. (A–D) Hematoxylin
and eosin staining of mouse pituitary gland from Manf+/+ (A,C) and Manf−/− (B,D) mice at postnatal stage P42. (A,B) Scale bar, 500µm. (C,D) Scale bar, 50µm.
(E) Area of adenohypophysis normalized to body weight of the animal (mm2/g). Adenohypophysis area of Manf−/− (black bars, n = 6) pituitary glands was significantly
reduced compared to Manf+/+ (white bars, n = 5) mice at 6 weeks of age. (F) Ratio of granule-filled acidophilic cells (purple) representing somatotropes and
lactotropes compared to basophils (violet) was significantly reduced in the anterior lobe of Manf−/− pituitaries (n = 6) compared to those of Manf+/+ mice (n = 5).
(G–L) Double immunohistochemistry analysis with anti-MANF antibody (G,J) and antibodies against growth hormone (GH) (H) and prolactin (K) expressing cells.
MANF (red) was co-expressed with GH and prolactin (green) cells of the adenohypophysis (I,L). Cell nuclei were labeled with DAPI (blue). Scale bar, 20µm. (M–P)
Growth hormone (GH) (M,N) and Prolactin (PRL) (O,P) immunohistochemistry on sections from adenohypophyses from Manf+/+ (n = 4) (M,O) and Manf−/− (n = 5)
(N,P) mice at postnatal stage P42. Scale bar, 20µm. (Q,R) Ratio of GH- (Q) and PRL- (R) positive cells was significantly reduced in the adenohypophyses of Manf+/+
(n = 4) and Manf−/− (n = 5) mice at postnatal stage P42. (S) Proliferation of cells in the adenohypophyses assessed by Ki67-positive cells compared to total amount
of cells, n- numbers; Manf+/+ mice= 4, Manf−/− mice= 5. (T–V) Quantitative RT-qPCR analysis for expression levels of hormonal genes in the mouse pituitary gland
from Manf+/+ (white bars) and Manf−/− mice (black bars) at postnatal age P42. n = 9 mice per group. For Fsh (U) nad Lhd (V) mRNA levels. Manf+/+ male mice
(n = 3), Manf−/− male mice (n = 5), Manf+/+ female mice (n = 6), Manf−/− female mice (n = 5). (W) Quantitative RT-qPCR PCR analysis of UPR genes in the pituitary
glands from Manf+/+ (n = 10) (white bars) and Manf−/− (n = 11) (black bars) mice at postnatal age P42. Mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001 vs. the corresponding control.
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TABLE 2 | Table of MANF expression in mouse tissues assessed by different
techniques.
Mouse tissue qRT-PCR
Relative Manf
mRNA
level/β-actin
ELISA
MANF protein
levels, ng/mg
total protein
IHC
MANF
Pituitary gland ++++ ++++ +++++
Thyroid gland ++ ++ +++++
Adrenal gland ++ ++ ++++
Pancreas Not analyzed +++++ +++++
Islets +++++ Not analyzed +++++
Exocrine tissue +++++ Not analyzed +++++
Testis ++++ +++++ +++++
Ovary +++ ++ +++
Brain + +++ +++
Thymus + + ++
Lung ++ Not analyzed +
Heart ++ + +
Liver +++ ++++ +++
Salivary gland +++ ++++ +++++
Kidney + ++ +
Spleen + ++ +
Duodenum +++ Not analyzed +++
Jejunum +++ Not analyzed Not analyzed
Ileum ++ Not analyzed Not analyzed
Colon ++ Not analyzed Not analyzed
Muscle ++ + +
Brown adipose tissue
(BAT)
Not analyzed +++ ++
White adipose tissue
(WAT)
Not analyzed + +
proteinatlas.org/ENSG00000145050-MANF/tissue). Similarly to
the mouse brain, MANF was high in neurons but low or non-
existing in glial and endothelial cells in the human brain. In
endocrine glandular cells of the human thyroid and adrenal
glands and islets of Langerhans, MANF levels were moderate
or high. Similarly to glandular cells in mouse tissues, MANF
expression was high in glandular cells of the exocrine pancreas,
cells in seminiferous ducts, and fallopian tubules. In human
kidney, MANF expression was moderate in the tubules and low
in the glomeruli. In human liver hepatocytes, MANF expression
was high in accordance with data for mouse. In contrast to our
mouse data, MANF levels were low or non-existing in human
salivary gland, but similarly to mouse MANF expression was
low in human heart and muscle. In conclusion, similar high
MANF expression was detected in glandular cells of human
tissues compared to our mouse data, suggesting the importance
of MANF in both human and mouse for cells with high protein
synthesis and secretion.
In order to provide the clues for potentially distinct activities
of MANF and CDNF, we studied MANF and CDNF mRNA
and protein expression levels in mouse tissues. We observed
the expression of MANF and CDNF in all tissues that were
analyzed. Notably, CDNF protein levels appear generally lower
TABLE 3 | MANF expression in mouse tissues.
Mouse tissue qRT-PCR
Relative Manf
mRNA
level/β-actin
ELISA
MANF protein
levels, ng/mg
total protein
IHC
MANF
Pituitary gland P56 P56 P56
Thyroid gland P56 P56 P14
Adrenal gland P56 P56 P14
Pancreas Not analyzed P56 P1, P14, P56
(5)
Islets P56
(5)
Not analyzed P1, P14, P56
(5)
Exocrine tissue P56
(5)
Not analyzed P1, P14, P56
(5)
Testis P56 P56 P14
Ovary P56 P56 P14
Brain P56 P56 P14
Thymus P56 P56 P14
Lung P56 Not analyzed P14
Heart P56 P56 P14
Liver P56 P56 P14
Salivary gland P56 P56 P56
Kidney P56 P56 P14
Spleen P56 P56 P14
Duodenum P56 Not analyzed P14
Jejunum P56 Not analyzed Not analyzed
Ileum P56 Not analyzed Not analyzed
Colon P56 Not analyzed Not analyzed
Muscle P56 P56 P14
Brown adipose
tissue (BAT)
Not analyzed P56 P14
White adipose
tissue (WAT)
Not analyzed P56 P14
Spinal Cord Not analyzed Not analyzed P56
Dorsal root ganglia
(DRG)
Not analyzed Not analyzed P56
Celiac ganglia
(CLG)
Not analyzed Not analyzed P56
than MANF protein levels in mouse tissues. While high levels
of MANF was detected within mouse endocrine and exocrine
glands, similarly to previous studies (6), the highest levels of
CDNFwas observed in the tissues with high-energy demands and
oxidative roles including heart, muscle, testis, and BAT.
A number of studies have indicated that exogenous MANF is
protective for cells in different pathological conditions including
neurodegenerative, metabolic, and inflammatory diseases (14,
34). We have previously demonstrated vital roles for endogenous
MANF in pancreatic β-cells (5, 16). In this study, we explore
new roles for MANF in the pituitary gland. We found that
MANF was highly expressed already in the developing anterior
pituitary gland, the ectodermal derived Rathke’s pouch in
mice at E13.5. In adult mice, MANF was highly expressed in
anterior and intermediate parts of the pituitary gland. Previously
we demonstrated that global MANF-deficiency in Manf−/−
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mice resulted in a severe growth retardation, including a 40%
reduction in weight at 8 weeks of age compared to Manf+/+
mice (16). As growth retardation in human is associated with
hypopituitarism and growth hormone-deficiency (50), we set out
to study the effect of MANF-removal from the pituitary gland
in mice. Unexpectedly, we found that the size of the anterior
pituitary gland was reduced in Manf−/− mice probably due
to the decreased number of GH and PRL-producing cells and
reduced number of proliferating cells in the anterior pituitary.
The reason for the reduced proliferation was most likely due to
severe ER stress activating all three major UPR branches in the
Manf−/− pituitary glands. In addition, mRNA levels for Gh and
Prl genes were reduced and proportionally the levels of Tshβ
and Pomc transcripts were increased, confirming the reduced
number of somatotropes and lactotropes in Manf−/− anterior
pituitary gland. The reduced number of GH-expressing cells as
well as reduced proportional levels of Gh mRNA expression
would suggest reduced levels of circulating GH in the Manf−/−
mice thus contributing to the growth defect. GH is important for
tissue growth and remodeling through inducing the expression
of insulin growth factor-1 mRNA in the liver leading to increased
release of IGF-1 into the bloodstream (56). However, the growth
retardation in GH-deficient mutant mice starts only 2 weeks after
birth (57), whereas Igf1−/− mice are 35% smaller than wild-type
mice at birth (58). As Manf−/− mice are already significantly
smaller than their wild-type litter-mates at E18.5 before birth
(16), the growth retardation in Manf−/− mice cannot solely be
due to reduced GH expression.
A recent study has identified the importance of MANF
for skeletal growth (59). Cartilage-specific ablation of Manf in
mice led to skeletal dysplasias caused by reduced chondrocyte
proliferation and increased ER stress. However, the skeletal
MANF-deficiency in these mice resulted in only a very mild
defect in long bone growth (about 5%), while the body
length in Manf−/− mice was reduced by 16% at 8 weeks of
age. Interestingly, Perk−/− mice were found normal at birth
but showed a severe postnatal growth retardation, skeletal
dysplasias and osteopenia followed by a loss of endocrine and
exocrine functions of the pancreas (25). Interestingly, the growth
retardation was found to be caused by decreased neonatal Igf-
1 expression in the liver but not from other tissues, leading to
reduced circulating IGF-1 serum levels important for neonatal
growth (60). It has been speculated that PERK may be required
in the liver for the translational initiation of one or more
factors that control the neonatal expression of Igf-1 mRNA.
As both IGF-1 and IGF-2 are important for embryonic growth
(61), MANF-deficiency might affect the expression of these
growth factors or proteins in general through increased ER stress
leading to PERK activation, increased eIF2α phosphorylation
and attenuation of translational initiation thus attenuating cell
proliferation and growth.
Our findings show that MANF is widely expressed in different
cells and tissues in the mouse, but its expression is especially high
in glandular and metabolically active cells with high synthesis
of secreted proteins. The expression levels of MANF seems
to be cell-specific, tightly regulated, and conserved in human
and mouse. Lack of MANF expression in MANF conventional
knockout mice leads to ER stress in pituitary gland resulting
in reduced proliferation and loss of GH- and PRL expressing
endocrine cells thereby probably contributing to the retarded
growth in Manf−/− mice. Thus, cells under higher basal ER
stress might require more MANF for proper protein folding to
maintain the ER homeostasis.
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